#news #biotech Amgen, Carmot ink backloaded $240M Parkinson’s pact

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Amgen, Carmot ink backloaded $240M Parkinson’s pact .Amgen has struck a deal with Carmot Therapeutics worth a potential $240 million. The alliance tasks Carmot with using its lead-identification technology to provide Amgen with a stream of prospects against conditions including Parkinson’s disease.

from FierceBiotech: Biotech http://ift.tt/2k0oDfU